 | • レポートコード：MRC2-11QY10174 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は無菌注射薬のグローバル市場について調査・分析したレポートです。種類別（サイトカイン、インスリン、ペプチドホルモン、ワクチン、免疫グロブリン、血液因子、ペプチド抗生物質、その他）市場規模、用途別（がん、糖尿病、心血管疾患、筋骨格系、中枢神経系、感染症、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別無菌注射薬の競争状況、市場シェア ・世界の無菌注射薬市場：種類別市場規模 2015年-2020年（サイトカイン、インスリン、ペプチドホルモン、ワクチン、免疫グロブリン、血液因子、ペプチド抗生物質、その他） ・世界の無菌注射薬市場：種類別市場規模予測 2021年-2026年（サイトカイン、インスリン、ペプチドホルモン、ワクチン、免疫グロブリン、血液因子、ペプチド抗生物質、その他） ・世界の無菌注射薬市場：用途別市場規模 2015年-2020年（がん、糖尿病、心血管疾患、筋骨格系、中枢神経系、感染症、その他） ・世界の無菌注射薬市場：用途別市場規模予測 2021年-2026年（がん、糖尿病、心血管疾患、筋骨格系、中枢神経系、感染症、その他） ・北米の無菌注射薬市場分析：米国、カナダ ・ヨーロッパの無菌注射薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの無菌注射薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の無菌注射薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの無菌注射薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Baxter International、Sanofi、GlaxoSmithKline、AstraZeneca、Merck、Novartis、Pfizer、GILEAD SCIENCES、Johnson & Johnson Services ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Sterile injectable drugs are sterile, parenteral preparations containing one more Active Pharmaceutical Ingredient (API) intended for administration into the body.
Growth of the global sterile injectable drugs is primarily driven by increasing demand for novel drug delivery systems, rising prevalence of chronic diseases, increasing public private partnerships and also rising awareness towards the use of sterile injectable drugs.
Market Analysis and Insights: Global Sterile Injectable Drugs Market
The global Sterile Injectable Drugs market size is projected to reach US$ 3599.4 million by 2026, from US$ 3408 million in 2020, at a CAGR of 5.2%% during 2021-2026.
Global Sterile Injectable Drugs Scope and Market Size
Sterile Injectable Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Sterile Injectable Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Sterile Injectable Drugs market is segmented into
Cytokines
Insulin
Peptide hormones
Vaccines
Immunoglobulins
Blood Factors
Peptide antibiotics
Others
Segment by Application, the Sterile Injectable Drugs market is segmented into
Cancer
Diabetes
Cardiovascular Diseases
Musculoskeletal
CNS
Infections
Others
Regional and Country-level Analysis
The Sterile Injectable Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Sterile Injectable Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Sterile Injectable Drugs Market Share Analysis
Sterile Injectable Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Sterile Injectable Drugs business, the date to enter into the Sterile Injectable Drugs market, Sterile Injectable Drugs product introduction, recent developments, etc.
The major vendors covered:
Baxter International
Sanofi
GlaxoSmithKline
AstraZeneca
Merck
Novartis
Pfizer
GILEAD SCIENCES
Johnson & Johnson Services
1 Study Coverage
1.1 Sterile Injectable Drugs Product Introduction
1.2 Market Segments
1.3 Key Sterile Injectable Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Sterile Injectable Drugs Market Size Growth Rate by Type
1.4.2 Cytokines
1.4.3 Insulin
1.4.4 Peptide hormones
1.4.5 Vaccines
1.4.6 Immunoglobulins
1.4.7 Blood Factors
1.4.8 Peptide antibiotics
1.4.9 Others
1.5 Market by Application
1.5.1 Global Sterile Injectable Drugs Market Size Growth Rate by Application
1.5.2 Cancer
1.5.3 Diabetes
1.5.4 Cardiovascular Diseases
1.5.5 Musculoskeletal
1.5.6 CNS
1.5.7 Infections
1.5.8 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Sterile Injectable Drugs Market Size, Estimates and Forecasts
2.1.1 Global Sterile Injectable Drugs Revenue 2015-2026
2.1.2 Global Sterile Injectable Drugs Sales 2015-2026
2.2 Global Sterile Injectable Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Sterile Injectable Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Sterile Injectable Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Sterile Injectable Drugs Competitor Landscape by Players
3.1 Sterile Injectable Drugs Sales by Manufacturers
3.1.1 Sterile Injectable Drugs Sales by Manufacturers (2015-2020)
3.1.2 Sterile Injectable Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Sterile Injectable Drugs Revenue by Manufacturers
3.2.1 Sterile Injectable Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Sterile Injectable Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Sterile Injectable Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Sterile Injectable Drugs Revenue in 2019
3.2.5 Global Sterile Injectable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Sterile Injectable Drugs Price by Manufacturers
3.4 Sterile Injectable Drugs Manufacturing Base Distribution, Product Types
3.4.1 Sterile Injectable Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Sterile Injectable Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Sterile Injectable Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Sterile Injectable Drugs Market Size by Type (2015-2020)
4.1.1 Global Sterile Injectable Drugs Sales by Type (2015-2020)
4.1.2 Global Sterile Injectable Drugs Revenue by Type (2015-2020)
4.1.3 Sterile Injectable Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Sterile Injectable Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Sterile Injectable Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Sterile Injectable Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Sterile Injectable Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Sterile Injectable Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Sterile Injectable Drugs Market Size by Application (2015-2020)
5.1.1 Global Sterile Injectable Drugs Sales by Application (2015-2020)
5.1.2 Global Sterile Injectable Drugs Revenue by Application (2015-2020)
5.1.3 Sterile Injectable Drugs Price by Application (2015-2020)
5.2 Sterile Injectable Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Sterile Injectable Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Sterile Injectable Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Sterile Injectable Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Sterile Injectable Drugs by Country
6.1.1 North America Sterile Injectable Drugs Sales by Country
6.1.2 North America Sterile Injectable Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Sterile Injectable Drugs Market Facts & Figures by Type
6.3 North America Sterile Injectable Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Sterile Injectable Drugs by Country
7.1.1 Europe Sterile Injectable Drugs Sales by Country
7.1.2 Europe Sterile Injectable Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Sterile Injectable Drugs Market Facts & Figures by Type
7.3 Europe Sterile Injectable Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Sterile Injectable Drugs by Region
8.1.1 Asia Pacific Sterile Injectable Drugs Sales by Region
8.1.2 Asia Pacific Sterile Injectable Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Sterile Injectable Drugs Market Facts & Figures by Type
8.3 Asia Pacific Sterile Injectable Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Sterile Injectable Drugs by Country
9.1.1 Latin America Sterile Injectable Drugs Sales by Country
9.1.2 Latin America Sterile Injectable Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Sterile Injectable Drugs Market Facts & Figures by Type
9.3 Central & South America Sterile Injectable Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Sterile Injectable Drugs by Country
10.1.1 Middle East and Africa Sterile Injectable Drugs Sales by Country
10.1.2 Middle East and Africa Sterile Injectable Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Sterile Injectable Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Sterile Injectable Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Baxter International
11.1.1 Baxter International Corporation Information
11.1.2 Baxter International Description and Business Overview
11.1.3 Baxter International Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxter International Sterile Injectable Drugs Products Offered
11.1.5 Baxter International Related Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Description and Business Overview
11.2.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sanofi Sterile Injectable Drugs Products Offered
11.2.5 Sanofi Related Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Corporation Information
11.3.2 GlaxoSmithKline Description and Business Overview
11.3.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GlaxoSmithKline Sterile Injectable Drugs Products Offered
11.3.5 GlaxoSmithKline Related Developments
11.4 AstraZeneca
11.4.1 AstraZeneca Corporation Information
11.4.2 AstraZeneca Description and Business Overview
11.4.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.4.4 AstraZeneca Sterile Injectable Drugs Products Offered
11.4.5 AstraZeneca Related Developments
11.5 Merck
11.5.1 Merck Corporation Information
11.5.2 Merck Description and Business Overview
11.5.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Merck Sterile Injectable Drugs Products Offered
11.5.5 Merck Related Developments
11.6 Novartis
11.6.1 Novartis Corporation Information
11.6.2 Novartis Description and Business Overview
11.6.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Novartis Sterile Injectable Drugs Products Offered
11.6.5 Novartis Related Developments
11.7 Pfizer
11.7.1 Pfizer Corporation Information
11.7.2 Pfizer Description and Business Overview
11.7.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Pfizer Sterile Injectable Drugs Products Offered
11.7.5 Pfizer Related Developments
11.8 GILEAD SCIENCES
11.8.1 GILEAD SCIENCES Corporation Information
11.8.2 GILEAD SCIENCES Description and Business Overview
11.8.3 GILEAD SCIENCES Sales, Revenue and Gross Margin (2015-2020)
11.8.4 GILEAD SCIENCES Sterile Injectable Drugs Products Offered
11.8.5 GILEAD SCIENCES Related Developments
11.9 Johnson & Johnson Services
11.9.1 Johnson & Johnson Services Corporation Information
11.9.2 Johnson & Johnson Services Description and Business Overview
11.9.3 Johnson & Johnson Services Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Johnson & Johnson Services Sterile Injectable Drugs Products Offered
11.9.5 Johnson & Johnson Services Related Developments
11.1 Baxter International
11.1.1 Baxter International Corporation Information
11.1.2 Baxter International Description and Business Overview
11.1.3 Baxter International Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxter International Sterile Injectable Drugs Products Offered
11.1.5 Baxter International Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Sterile Injectable Drugs Market Estimates and Projections by Region
12.1.1 Global Sterile Injectable Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Sterile Injectable Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Sterile Injectable Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Sterile Injectable Drugs Sales Forecast (2021-2026)
12.2.2 North America: Sterile Injectable Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Sterile Injectable Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Sterile Injectable Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Sterile Injectable Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Sterile Injectable Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Sterile Injectable Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Sterile Injectable Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Sterile Injectable Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Sterile Injectable Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Sterile Injectable Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Sterile Injectable Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Sterile Injectable Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Sterile Injectable Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Sterile Injectable Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Sterile Injectable Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Sterile Injectable Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Sterile Injectable Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Sterile Injectable Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Sterile Injectable Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Sterile Injectable Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Sterile Injectable Drugs Market Segments
Table 2. Ranking of Global Top Sterile Injectable Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Sterile Injectable Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Cytokines
Table 5. Major Manufacturers of Insulin
Table 6. Major Manufacturers of Peptide hormones
Table 7. Major Manufacturers of Vaccines
Table 8. Major Manufacturers of Immunoglobulins
Table 9. Major Manufacturers of Blood Factors
Table 10. Major Manufacturers of Peptide antibiotics
Table 11. Major Manufacturers of Others
Table 12. Global Sterile Injectable Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Sterile Injectable Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 14. Global Sterile Injectable Drugs Sales by Regions 2015-2020 (K Units)
Table 15. Global Sterile Injectable Drugs Sales Market Share by Regions (2015-2020)
Table 16. Global Sterile Injectable Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Sterile Injectable Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Sterile Injectable Drugs Sales Share by Manufacturers (2015-2020)
Table 19. Global Sterile Injectable Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Sterile Injectable Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sterile Injectable Drugs as of 2019)
Table 21. Sterile Injectable Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Sterile Injectable Drugs Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Sterile Injectable Drugs Price (2015-2020) (USD/Unit)
Table 24. Sterile Injectable Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Sterile Injectable Drugs Product Type
Table 26. Date of International Manufacturers Enter into Sterile Injectable Drugs Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Sterile Injectable Drugs Sales by Type (2015-2020) (K Units)
Table 29. Global Sterile Injectable Drugs Sales Share by Type (2015-2020)
Table 30. Global Sterile Injectable Drugs Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Sterile Injectable Drugs Revenue Share by Type (2015-2020)
Table 32. Sterile Injectable Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 33. Global Sterile Injectable Drugs Sales by Application (2015-2020) (K Units)
Table 34. Global Sterile Injectable Drugs Sales Share by Application (2015-2020)
Table 35. North America Sterile Injectable Drugs Sales by Country (2015-2020) (K Units)
Table 36. North America Sterile Injectable Drugs Sales Market Share by Country (2015-2020)
Table 37. North America Sterile Injectable Drugs Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Sterile Injectable Drugs Revenue Market Share by Country (2015-2020)
Table 39. North America Sterile Injectable Drugs Sales by Type (2015-2020) (K Units)
Table 40. North America Sterile Injectable Drugs Sales Market Share by Type (2015-2020)
Table 41. North America Sterile Injectable Drugs Sales by Application (2015-2020) (K Units)
Table 42. North America Sterile Injectable Drugs Sales Market Share by Application (2015-2020)
Table 43. Europe Sterile Injectable Drugs Sales by Country (2015-2020) (K Units)
Table 44. Europe Sterile Injectable Drugs Sales Market Share by Country (2015-2020)
Table 45. Europe Sterile Injectable Drugs Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Sterile Injectable Drugs Revenue Market Share by Country (2015-2020)
Table 47. Europe Sterile Injectable Drugs Sales by Type (2015-2020) (K Units)
Table 48. Europe Sterile Injectable Drugs Sales Market Share by Type (2015-2020)
Table 49. Europe Sterile Injectable Drugs Sales by Application (2015-2020) (K Units)
Table 50. Europe Sterile Injectable Drugs Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Sterile Injectable Drugs Sales by Region (2015-2020) (K Units)
Table 52. Asia Pacific Sterile Injectable Drugs Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Sterile Injectable Drugs Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Sterile Injectable Drugs Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Sterile Injectable Drugs Sales by Type (2015-2020) (K Units)
Table 56. Asia Pacific Sterile Injectable Drugs Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Sterile Injectable Drugs Sales by Application (2015-2020) (K Units)
Table 58. Asia Pacific Sterile Injectable Drugs Sales Market Share by Application (2015-2020)
Table 59. Latin America Sterile Injectable Drugs Sales by Country (2015-2020) (K Units)
Table 60. Latin America Sterile Injectable Drugs Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Sterile Injectable Drugs Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Sterile Injectable Drugs Revenue Market Share by Country (2015-2020)
Table 63. Latin America Sterile Injectable Drugs Sales by Type (2015-2020) (K Units)
Table 64. Latin America Sterile Injectable Drugs Sales Market Share by Type (2015-2020)
Table 65. Latin America Sterile Injectable Drugs Sales by Application (2015-2020) (K Units)
Table 66. Latin America Sterile Injectable Drugs Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Sterile Injectable Drugs Sales by Country (2015-2020) (K Units)
Table 68. Middle East and Africa Sterile Injectable Drugs Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Sterile Injectable Drugs Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Sterile Injectable Drugs Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Sterile Injectable Drugs Sales by Type (2015-2020) (K Units)
Table 72. Middle East and Africa Sterile Injectable Drugs Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Sterile Injectable Drugs Sales by Application (2015-2020) (K Units)
Table 74. Middle East and Africa Sterile Injectable Drugs Sales Market Share by Application (2015-2020)
Table 75. Baxter International Corporation Information
Table 76. Baxter International Description and Major Businesses
Table 77. Baxter International Sterile Injectable Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Baxter International Product
Table 79. Baxter International Recent Development
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Major Businesses
Table 82. Sanofi Sterile Injectable Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Sanofi Product
Table 84. Sanofi Recent Development
Table 85. GlaxoSmithKline Corporation Information
Table 86. GlaxoSmithKline Description and Major Businesses
Table 87. GlaxoSmithKline Sterile Injectable Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. GlaxoSmithKline Product
Table 89. GlaxoSmithKline Recent Development
Table 90. AstraZeneca Corporation Information
Table 91. AstraZeneca Description and Major Businesses
Table 92. AstraZeneca Sterile Injectable Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. AstraZeneca Product
Table 94. AstraZeneca Recent Development
Table 95. Merck Corporation Information
Table 96. Merck Description and Major Businesses
Table 97. Merck Sterile Injectable Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Merck Product
Table 99. Merck Recent Development
Table 100. Novartis Corporation Information
Table 101. Novartis Description and Major Businesses
Table 102. Novartis Sterile Injectable Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Novartis Product
Table 104. Novartis Recent Development
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Major Businesses
Table 107. Pfizer Sterile Injectable Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Pfizer Product
Table 109. Pfizer Recent Development
Table 110. GILEAD SCIENCES Corporation Information
Table 111. GILEAD SCIENCES Description and Major Businesses
Table 112. GILEAD SCIENCES Sterile Injectable Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. GILEAD SCIENCES Product
Table 114. GILEAD SCIENCES Recent Development
Table 115. Johnson & Johnson Services Corporation Information
Table 116. Johnson & Johnson Services Description and Major Businesses
Table 117. Johnson & Johnson Services Sterile Injectable Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Johnson & Johnson Services Product
Table 119. Johnson & Johnson Services Recent Development
Table 120. Global Sterile Injectable Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 121. Global Sterile Injectable Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 122. Global Sterile Injectable Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 123. Global Sterile Injectable Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 124. North America: Sterile Injectable Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 125. North America: Sterile Injectable Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Europe: Sterile Injectable Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 127. Europe: Sterile Injectable Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Asia Pacific: Sterile Injectable Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 129. Asia Pacific: Sterile Injectable Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 130. Latin America: Sterile Injectable Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 131. Latin America: Sterile Injectable Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Middle East and Africa: Sterile Injectable Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 133. Middle East and Africa: Sterile Injectable Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 135. Key Challenges
Table 136. Market Risks
Table 137. Main Points Interviewed from Key Sterile Injectable Drugs Players
Table 138. Sterile Injectable Drugs Customers List
Table 139. Sterile Injectable Drugs Distributors List
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Sterile Injectable Drugs Product Picture
Figure 2. Global Sterile Injectable Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Cytokines Product Picture
Figure 4. Insulin Product Picture
Figure 5. Peptide hormones Product Picture
Figure 6. Vaccines Product Picture
Figure 7. Immunoglobulins Product Picture
Figure 8. Blood Factors Product Picture
Figure 9. Peptide antibiotics Product Picture
Figure 10. Others Product Picture
Figure 11. Global Sterile Injectable Drugs Sales Market Share by Application in 2020 & 2026
Figure 12. Cancer
Figure 13. Diabetes
Figure 14. Cardiovascular Diseases
Figure 15. Musculoskeletal
Figure 16. CNS
Figure 17. Infections
Figure 18. Others
Figure 19. Sterile Injectable Drugs Report Years Considered
Figure 20. Global Sterile Injectable Drugs Market Size 2015-2026 (US$ Million)
Figure 21. Global Sterile Injectable Drugs Sales 2015-2026 (K Units)
Figure 22. Global Sterile Injectable Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 23. Global Sterile Injectable Drugs Sales Market Share by Region (2015-2020)
Figure 24. Global Sterile Injectable Drugs Sales Market Share by Region in 2019
Figure 25. Global Sterile Injectable Drugs Revenue Market Share by Region (2015-2020)
Figure 26. Global Sterile Injectable Drugs Revenue Market Share by Region in 2019
Figure 27. Global Sterile Injectable Drugs Sales Share by Manufacturer in 2019
Figure 28. The Top 10 and 5 Players Market Share by Sterile Injectable Drugs Revenue in 2019
Figure 29. Sterile Injectable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Sterile Injectable Drugs Sales Market Share by Type (2015-2020)
Figure 31. Global Sterile Injectable Drugs Sales Market Share by Type in 2019
Figure 32. Global Sterile Injectable Drugs Revenue Market Share by Type (2015-2020)
Figure 33. Global Sterile Injectable Drugs Revenue Market Share by Type in 2019
Figure 34. Global Sterile Injectable Drugs Market Share by Price Range (2015-2020)
Figure 35. Global Sterile Injectable Drugs Sales Market Share by Application (2015-2020)
Figure 36. Global Sterile Injectable Drugs Sales Market Share by Application in 2019
Figure 37. Global Sterile Injectable Drugs Revenue Market Share by Application (2015-2020)
Figure 38. Global Sterile Injectable Drugs Revenue Market Share by Application in 2019
Figure 39. North America Sterile Injectable Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 40. North America Sterile Injectable Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. North America Sterile Injectable Drugs Sales Market Share by Country in 2019
Figure 42. North America Sterile Injectable Drugs Revenue Market Share by Country in 2019
Figure 43. U.S. Sterile Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 44. U.S. Sterile Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Canada Sterile Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 46. Canada Sterile Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. North America Sterile Injectable Drugs Market Share by Type in 2019
Figure 48. North America Sterile Injectable Drugs Market Share by Application in 2019
Figure 49. Europe Sterile Injectable Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 50. Europe Sterile Injectable Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 51. Europe Sterile Injectable Drugs Sales Market Share by Country in 2019
Figure 52. Europe Sterile Injectable Drugs Revenue Market Share by Country in 2019
Figure 53. Germany Sterile Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 54. Germany Sterile Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. France Sterile Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 56. France Sterile Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. U.K. Sterile Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 58. U.K. Sterile Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Italy Sterile Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 60. Italy Sterile Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Russia Sterile Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 62. Russia Sterile Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Europe Sterile Injectable Drugs Market Share by Type in 2019
Figure 64. Europe Sterile Injectable Drugs Market Share by Application in 2019
Figure 65. Asia Pacific Sterile Injectable Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 66. Asia Pacific Sterile Injectable Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 67. Asia Pacific Sterile Injectable Drugs Sales Market Share by Region in 2019
Figure 68. Asia Pacific Sterile Injectable Drugs Revenue Market Share by Region in 2019
Figure 69. China Sterile Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. China Sterile Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Japan Sterile Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. Japan Sterile Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. South Korea Sterile Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. South Korea Sterile Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. India Sterile Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. India Sterile Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Australia Sterile Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Australia Sterile Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Taiwan Sterile Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Taiwan Sterile Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Indonesia Sterile Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 82. Indonesia Sterile Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Thailand Sterile Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 84. Thailand Sterile Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Malaysia Sterile Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 86. Malaysia Sterile Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Philippines Sterile Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 88. Philippines Sterile Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Vietnam Sterile Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 90. Vietnam Sterile Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Asia Pacific Sterile Injectable Drugs Market Share by Type in 2019
Figure 92. Asia Pacific Sterile Injectable Drugs Market Share by Application in 2019
Figure 93. Latin America Sterile Injectable Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 94. Latin America Sterile Injectable Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 95. Latin America Sterile Injectable Drugs Sales Market Share by Country in 2019
Figure 96. Latin America Sterile Injectable Drugs Revenue Market Share by Country in 2019
Figure 97. Mexico Sterile Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 98. Mexico Sterile Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Brazil Sterile Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 100. Brazil Sterile Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Argentina Sterile Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 102. Argentina Sterile Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Latin America Sterile Injectable Drugs Market Share by Type in 2019
Figure 104. Latin America Sterile Injectable Drugs Market Share by Application in 2019
Figure 105. Middle East and Africa Sterile Injectable Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 106. Middle East and Africa Sterile Injectable Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 107. Middle East and Africa Sterile Injectable Drugs Sales Market Share by Country in 2019
Figure 108. Middle East and Africa Sterile Injectable Drugs Revenue Market Share by Country in 2019
Figure 109. Turkey Sterile Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 110. Turkey Sterile Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 111. Saudi Arabia Sterile Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 112. Saudi Arabia Sterile Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 113. U.A.E Sterile Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 114. U.A.E Sterile Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 115. Middle East and Africa Sterile Injectable Drugs Market Share by Type in 2019
Figure 116. Middle East and Africa Sterile Injectable Drugs Market Share by Application in 2019
Figure 117. North America Sterile Injectable Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. North America Sterile Injectable Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Europe Sterile Injectable Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. Europe Sterile Injectable Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Asia Pacific Sterile Injectable Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 122. Asia Pacific Sterile Injectable Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Latin America Sterile Injectable Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 124. Latin America Sterile Injectable Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Middle East and Africa Sterile Injectable Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 126. Middle East and Africa Sterile Injectable Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Porter's Five Forces Analysis
Figure 128. Channels of Distribution
Figure 129. Distributors Profiles
Figure 130. Bottom-up and Top-down Approaches for This Report
Figure 131. Data Triangulation
Figure 132. Key Executives Interviewed
注射薬の世界市場（～2026年） Drug injection is a method of introducing a drug into the bloodstream via a hollow hypodermic needle and a syringe, which is pierced through the skin into the body. Injectable drugs bypasses first-pass metabolism in the liver, resulting in higher bioavailability and efficiency for many drugs (such a…- 病院用注射薬の世界市場（～2026年） Drug injection is a method of introducing a drug into the bloodstream via a hollow hypodermic needle and a syringe, which is pierced through the skin into the body. Injectable drugs bypasses first-pass metabolism in the liver, resulting in higher bioavailability and efficiency for many drugs (such a…
- 非滅菌調剤薬の世界市場（～2026年） Nonsterile drug compounding is the practice of preparing specific medication doses for patients to drink, swallow, insert or apply to the skin. It is the most common kind of drug compounding done by pharmacists and pharmacy technicians in community and hospital pharmacies. And despite its "nonsteril…
- 無菌バリアシステムの世界市場（～2026年） In protective packaging, protective measures are created to prevent damage to the so-called sterile barrier system while not in use up to the time that it’s needed. The Sterile Barrier System refers to the minimum packaging that prevents proliferation of microorganisms and sterilizing the product to…
- 注射可能型ドラッグデリバリーの世界市場（～2026年） Injectable drug delivery is defined as introduction of a drug or drugs in the patient by using a delivery device. Injectables allow the transport of drugs formulated in liquid form, directly in the body. Even though, they may be designed to transport the drug to specific part of the body. North Amer…